Antigal, Apple A.

HRN: 16-69-65  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/30/2022
CEFUROXIME 1.5GM (VIAL)
11/30/2022
11/30/2022
IV
1.5g
LD
Preop Prophylaxis
Waiting Final Action 
11/30/2022
CO-AMOXICLAV 625MG (TAB)
11/30/2022
12/07/2022
ORAL
625mg
Q12
S/P Completion Curettage
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: